自身免疫性肝病外周血中性粒细胞变化研究进展:机制、诊断与治疗新视角*

doi:10.3969/j.issn.1672-5069.2026.03.001

Abstract

Li Ning, Wang Yan, Lei Hongtao, et al. Neutrophils in patients with autoimmune liver diseases: new perspectives on mechanisms, diagnosis and treatment[J]. Journal of Practical Hepatology, 2026, 29(3): 321-323.

References

[1] Lleo A, Wang GQ, Gershwin ME, et al. Primary biliary cholangitis. Lancet, 2020,396(10266):1915-1926.
[2] Amulic B, Cazalet C, Hayes GL, et al. Neutrophil function: from mechanisms to disease. Annu Rev Immunol, 2012,30:459-489.
[3] Zhang F, Xia Y, SU J, et al. Neutrophil diversity and function in health and disease. Signal Transduct Target Ther, 2024,9(1):343.
[4] Wang X, He Z, Liu H, et al. Neutrophil necroptosis is triggered by ligation of adhesion molecules following GM-CSF priming. J Immunol,2016,197(10):4090-4100.
[5] Tu H, Ren H, Jiang J, et al. Dying to defend: neutrophil death pathways and their implications in immunity. Adv Sci (Weinh),2024,11(8):e2306457.
[6] Brinkmann, Reichard U, Goosmann C, et al. Neutrophil extracellular traps kill bacteria. Science, 2004,303(5663):1532-1535.
[7] Vorobjeva NV, Pinegin BV. Neutrophil extracellular traps: mechanisms of formation and role in health and disease. Biochemistry (Mosc),2014,79(12):1286-1296.
[8] Morales-Primo AU, Becker I, Zamora-Chimal J. Neutrophil extracellular trap-associated molecules: a review on their immunophysiological and inflammatory roles. Int Rev Immunol, 2022,41(2):253-274.
[9] Wigerblad G, Kaplan MJ. Neutrophil extracellular traps in systemic autoimmune and autoinflammatory diseases. Nat Rev Immunol,2023,23(5):274-288.
[10] Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol,2018,18(2):134-147.
[11] Ma Y, Wei J, He W, et al. Neutrophil extracellular traps in cancer. Med Comm (2020),2024,5(8):e647.
[12] Delgado-Rizo V, Martínez-Guzmán MA, Iñiguez-Gutierrez L, et al. Neutrophil extracellular traps and its implications in Inflammation: an overview. Front Immunol,2017,8:81.
[13] Yipp BG, Kubes P. NETosis: how vital is it? Blood,2013,122(16):2784-2794.
[14] Vorobjeva NV, Chernyak BV. NETosis: molecular mechanisms, role in physiology and pathology. Biochemistry(Mosc),2020,85(10):1178-1190.
[15] Levitz SM, Urban CF, Ermert D, et al. Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against candida albicans. PLoS Pathog,2009,5(10):e1000639.
[16] Abrams ST, Zhang N, Manson J, et al. Circulating histones are mediators of trauma-associated lung injury. Am J Respir Crit Care Med,2013,187(2):160-169.
[17] Glogauer M, O’donoghue AJ, Jin Y, et al. Global substrate profiling of proteases in human neutrophil extracellular traps reveals consensus motif predominantly contributed by elastase. PLoS One,2013,8(9):e75141.
[18] Hasler P, Giaglis S, Hahn S. Neutrophil extracellular traps in health and disease. Swiss Med Wkly,2016,146:w14352.
[19] Zeng FL, Zhang Y, Wang ZH, et al. Neutrophil extracellular traps promote acetaminophen-induced acute liver injury in mice via AIM2. Acta Pharmacol Sin,2024,45(8):1660-1672.
[20] Yu M, Li X, Xu L, et al. Neutrophil extracellular traps induce intrahepatic thrombotic tendency and liver damage in cholestatic liver disease. Hepatol Commun,2024,8(8):e0513.
[21] Huang J, Hong W, Wan M, et al. Molecular mechanisms and therapeutic target of NETosis in diseases. MedComm (2020),2022,3(3):e162.
[22] Wang L, Luqmani R, Udalova IA. The role of neutrophils in rheumatic disease-associated vascular inflammation. Nat Rev Rheumatol,2022,18(3):158-170.

Neutrophils in patients with autoimmune liver diseases: new perspectives on mechanisms, diagnosis and treatment

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Cui Yeqi, Zhang Shibin. Classification and formation mechanism of portal vein thrombosis in patients with liver cirrhosis [J]. Journal of Practical Hepatology, 2025, 28(2): 161-164.
[2]	Chen Datong, Yue Zhanyi, Zhang Xiaopeng. Single nucleotide polymorphism of Rs3184504 in SH2B3 gene in patients with autoimmune liver disease [J]. Journal of Practical Hepatology, 2024, 27(6): 856-859.
[3]	Ren Hao, Xiong Qingfang. Diagnostic performance of fournoninvasive detection indexes in predicting liver cirrhosis in patients with autoimmune liver diseases [J]. Journal of Practical Hepatology, 2024, 27(4): 535-538.
[4]	Huang Long, Fan Yaxi, Duan Zhongping. Mechanism of Shuganning’s roles in promoting gallbladder motion, relieving jaundice, anti-inflammatory and protecting liver functions [J]. Journal of Practical Hepatology, 2023, 26(5): 765-768.
[5]	Zhen Yongli , Zhang Yafei , Zhang Zhenhua. Changes of thyroid hormone in patients with autoimmune liver diseases [J]. Journal of Practical Hepatology, 2023, 26(4): 508-511.
[6]	Sun Cui, Cao Linlin, Liu Jun. Prevalence of serum autoantibody spectrums in patients with different liver diseases [J]. Journal of Practical Hepatology, 2023, 26(3): 368-371.
[7]	Zhu Xinwen, Wang Weibing, Yuan Fubing, et al. Combination of NLR and serum IL-6 level in predicting 28-day mortality in patients with acute-on-chronic hepatitis B liver failure [J]. Journal of Practical Hepatology, 2023, 26(1): 67-70.
[8]	Wang Qixia, Ma Xiong. Insights to precision medicine and clinical translational research in patients with autoimmune liver diseases [J]. Journal of Practical Hepatology, 2021, 24(4): 457-459.
[9]	Zhang Jianrong, Gu Erli, Wang Zhongcheng, et al. Comparison of clinical characteristics of patients with autoimmune hepatitis, primary biliary cholangitis and AIH/PBC overlap syndrome [J]. Journal of Practical Hepatology, 2020, 23(6): 829-832.
[10]	Pan Hongduo, Dang Tong, Zhou Yi, et al. Terlipressin in combination with albumin infusion for patients with cirrhosis and type Ⅱ hepatorenal syndrome [J]. Journal of Practical Hepatology, 2020, 23(6): 861-864.
[11]	Pan Meimin, Li Wenjuan, Jiang Fangqing, et al.. Changes of serum IL-17A,fibroblast growth factor and IL-7 levels in patients with hepatitis C virus infection [J]. Journal of Practical Hepatology, 2019, 22(6): 840-843.
[12]	Zhang Rui, Wang Jian, Chen Shiyao.. Mechanism of portal vein thrombosis in cirrhotic patients with portal hypertension and the treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 930-933.
[13]	Xiao Han, Wang Li. Mechanisms of thrombocytopenia in liver cirrhosis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 462-465.
[14]	Xia Geng, Qi Fei, Yang Jinhui.. Predisposing factors to autoimmune hepatitis [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 983-986.
[15]	Fang Xudong, Fang Xiaoming, Chen Dawei, et al. Application of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in forecasting prognosis of patients with primary liver cancer underwent TACE [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(3): 431-434.